BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18223219)

  • 1. Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer.
    Hassan S; Baccarelli A; Salvucci O; Basik M
    Clin Cancer Res; 2008 Jan; 14(2):446-54. PubMed ID: 18223219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma.
    Razmkhah M; Talei AR; Doroudchi M; Khalili-Azad T; Ghaderi A
    Cancer Lett; 2005 Jul; 225(2):261-6. PubMed ID: 15978329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer.
    Razmkhah M; Doroudchi M; Ghayumi SM; Erfani N; Ghaderi A
    Lung Cancer; 2005 Sep; 49(3):311-5. PubMed ID: 15955592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating stromal cell derived factor-1alpha (SDF-1alpha) is predictive of distant metastasis in gastric carcinoma.
    Woo IS; Hong SH; Byun JH; Kang JH; Jeon HM; Choi MG
    Cancer Invest; 2008; 26(3):256-61. PubMed ID: 18317966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.
    Soriano A; Martínez C; García F; Plana M; Palou E; Lejeune M; Aróstegui JI; De Lazzari E; Rodriguez C; Barrasa A; Lorenzo JI; Alcamí J; del Romero J; Miró JM; Gatell JM; Gallart T
    J Infect Dis; 2002 Oct; 186(7):922-31. PubMed ID: 12232832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
    Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
    J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
    Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
    Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
    Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection.
    van Rij RP; Broersen S; Goudsmit J; Coutinho RA; Schuitemaker H
    AIDS; 1998 Jun; 12(9):F85-90. PubMed ID: 9662191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the stromal cell-derived factor-1-3'A and E-selectin S128R polymorphisms on breast cancer.
    Kontogianni P; Zambirinis CP; Theodoropoulos G; Gazouli M; Michalopoulos NV; Flessas J; Liberi M; Zografos GC
    Mol Biol Rep; 2013 Jan; 40(1):43-50. PubMed ID: 23129313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer.
    Teng YH; Liu TH; Tseng HC; Chung TT; Yeh CM; Li YC; Ou YH; Lin LY; Tsai HT; Yang SF
    Head Neck; 2009 Oct; 31(10):1282-8. PubMed ID: 19373784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
    Dimberg J; Hugander A; Löfgren S; Wågsäter D
    Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival.
    Zhang X; Shu XO; Cai Q; Ruan Z; Gao YT; Zheng W
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6037-42. PubMed ID: 17062678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma stromal cell-derived factor 1 protein and its gene polymorphism in patients with pelvic inflammatory disease.
    Tsai HT; Tee YT; Hsieh YH; Chiou HL; Lin CW; Tsai HC; Wang PH; Yang SF
    Reprod Sci; 2009 Jun; 16(6):610-7. PubMed ID: 19282275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast.
    Liu F; Lang R; Wei J; Fan Y; Cui L; Gu F; Guo X; Pringle GA; Zhang X; Fu L
    Histopathology; 2009 May; 54(6):741-50. PubMed ID: 19438749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil.
    de Oliveira Cavassin GG; De Lucca FL; Delgado André N; Covas DT; Pelegrinelli Fungaro MH; Voltarelli JC; Watanabe MA
    Blood Cells Mol Dis; 2004; 33(1):90-3. PubMed ID: 15223017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival.
    Mirisola V; Zuccarino A; Bachmeier BE; Sormani MP; Falter J; Nerlich A; Pfeffer U
    Eur J Cancer; 2009 Sep; 45(14):2579-87. PubMed ID: 19646861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
    Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
    Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.